Novel circulating tumor cell‑detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
Masatoshi Kanayama(University of Occupational and Environmental Health Japan), Fumihiro Tanaka(University of Occupational and Environmental Health Japan)
Cited by 10
Related Papers
CD155 expression and its clinical significance in non‑small cell lung cancer
|Oncology Letters|2022|36
Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma
|Cancer Science|2018|30
Prognostic impact of programmed death-ligand 1 expression in correlation with human leukocyte antigen class I expression status in stage I adenocarcinoma of the lung
|Journal of Thoracic and Cardiovascular Surgery|2017|29